期刊文献+

细胞密度和营养供给对H1N1流感病毒产率的影响 被引量:4

Effect of Cell Density and Nutrition Supply on Cell-specific Virus Yields of Influenza Virus H1N1
下载PDF
导出
摘要 探究细胞培养生产流感病毒过程中,高细胞密度引起低单位细胞病毒产率(Svy)的原因及找到解决方法。通过增加微载体浓度以及换液操作获得较高的细胞密度;考察了感染时细胞密度(CCI)和病毒感染用维持培养基对病毒产量和单位细胞病毒产率的影响。在12.6 g/L微载体培养过程中,通过换液操作,可获得高细胞密度,达到1.47×107 cells/m L。在CCI为1×107cells/m L条件时,选择合适的维持培养基,其Svy最高达到5.14×103 virions/cell,比同等条件下用DMEM维持培养基的Svy值提高了近一倍。高密度培养MDCK细胞生产流感病毒时,充分考虑不同阶段的培养条件和营养需求,可以提高细胞密度和单位细胞病毒产率,进而提高流感病毒的产量。该研究结果为工业化生产流感病毒疫苗提供了基础数据。 It was to investigate the phenomenon that high cell density with low cell-specific virus yields and find out the solution. Methods:High cell density was achieved by increasing the microcarrier concentration and enhancing nutrition supply, then the effect of cell concentration at infection(CCI)and virus maintenance medium(VMM)on virus titer and cell-specific virus yield(Svy)was studied. Results:The maximum cell density was up to 1.47×107cells/mL in 12.6 g/L microcarrier culture using medium exchange strategy. Under high CCI(1×107cells/mL)condition, the Svy was up to 5.14×103 virions/cell by choosing appropriate virus maintenance medium, which is nearly twice of Svy in DMEM. Conclusion:In order to achieve higher influenza virus titer, culture conditions and nutrition demands at different stages of influenza production should be taken into consideration. The results in this work provide guidance for further development of industrial-scale vaccine production processes.
出处 《生物技术通报》 CAS CSCD 北大核心 2015年第1期203-208,共6页 Biotechnology Bulletin
基金 国家自然科学基金项目(21106045 21206040) 国家"863"计划(2012AA02A303) 国家重大专项(2013ZX10004003-003-003) 中央高校基本科研业务费(WF1214035)
关键词 高密度培养 MDCK 流感 病毒 high-density culture MDCK influenza production virions
  • 相关文献

参考文献13

  • 1George M, Farooq M, Dang T, et al. Production of cell culture ( MD- CK ) derived live attenuated influenza vaccine ( LAIV ) in a fully disposable platform process [ J ] . Biotechnology and Bioengineer- ing, 2010, 106 ( 6 ) : 906-917.
  • 2Hu AYC, Weng TC, Tseng YF, et al. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines [ J ] . Vaccine, 2008, 26 : 5736-5740.
  • 3Bock A, Schulze-Horsel J, Schwarzer J, et al. High-density microcarrier cell cultures for influenza virus production [ J ] . Biotechnology Progress, 2011, 27 ( 1 ) : 241-50.
  • 4. Genzel Y, Behrendt I, Konig S, et al. Metabolism of MDCK ceils during cell growth and influenza virus production in large-scalemicrocarrier culture [ J ] . Vaccine, 2004, 22 ( 17-18 ) : 2202- 2208.
  • 5Genzel Y, Reiehl U. Continuous cell lines as a production system for influenza vaccines [ J ] . Vaccine, 2009, 8 ( 12 ) : 1681-1692.
  • 6Schulze-Horsel I, Schulze M, Agalaridis G, et al. Infection dynamics and virus-induced apoptosis in cell euhure-based influenza vaccine production-Flow cytometry and mathematical modeling [ J ] . Vaccine, 2009, 27 ( 20 ) : 2712-22.
  • 7Sun B, Yu X, Kong W, et al. Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor [ J ] . Applied Microbiology and Biotechnology, 2013, 97 ( 3 ) : 1063-70.
  • 8Lohr V, Genzel Y, Behrendt I, et al. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor [ J ] . Vaccine, 2010, 28 ( 38 ) : 6256-64.
  • 9Aggarwal K, Jing F, Maranga L, et 81. Bioprocess optimization for cell culture based influenza vaccine production [ J ] . Vaccine, 2011, 29 ( 17 ) : 3320-3328.
  • 10Maranga L, Brazfto TF, Carrondo MJT. Virus-like particle produc- tion at low multiplicities of infection with the baculovirus insect cell system [ J ] . Biotechnology and Bioengineering, 2003, 84 ( 2 ) : 245-253.

同被引文献46

  • 1戚凤春,汪春义,张雪梅,王亚军,李晓波,贾媛,赵大鹏,盛军.两种细胞培养流感病毒的滴度比较[J].中国生物制品学杂志,2006,19(3):291-292. 被引量:23
  • 2Henry O, Dormond E, Perrier M, et al. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures [ J ] . Biotechnology and Bioengineering, 2004, 86 ( 7 ) : 765-774.
  • 3Pohlscheidt M, Langer U, Minuth T, et al. Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell cuhure in a non-animal, non-human and non-plant-derived medium [ J ] . Vaccine, 2008, 26 ( 12 ) : 1552-1565.
  • 4Huang D, Xia-Hou K, Liu XP, et al. Rational design of medium supplementation strategy for improved influenza viruses production based on analyzing nutritional requirements of MDCK Ceils [ J ] . Vaccine, 2014, 32 ( 52 ) : 7091-7097.
  • 5Hatakeyama S, Sakai-Tagawa Y, Kiso M, et al. Enhanced expression of an a2, 6-11nked siMic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor [ J ] . Journal of Clinical Microbiology, 2005, 43 ( 8 ) : 4139-4146.
  • 6Olsen CW, Kehren JC, Dybdahl-Sissoko NR, et al. bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation [ J ] . Journal of Virology, 1996, 70 ( 1 ) : 663-666.
  • 7Tsao YS, Condon R, Schaefer E, et al. Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells [ J ] . Cytotechnology, 2001,37 ( 3 ) : 189-198.
  • 8Aggarwal K, Jing F, Maranga L, et al. Bioprocess optimization for cell culture based influenza vaccine production [ J ] . Vaccine, 2011, 29 ( 17 ) : 3320-3328.
  • 9Ferreira TB, Ferreira AL, Carrondo M J, et al. Effect of re-feed strategies and medium on adenovirus production at high cell densities [ J ]. J Biotechnol, 2005, 119 ( 3 ) : 272-280.
  • 10Ferreira TB, Ferreira AL, Carrondo MJ, et al. Two different serum- free media and osmolality effect upon human 293 cell growth and adenovirus production [ J ] . Biotechnol Lett, 2005, 27 ( 22 ) : 1809-1813.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部